Kascaid is developing biosensors for real-time monitoring of inflammatory biomarkers.
Kascaid has raised $2.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.
Kascaid's investors include Draper Associates, 2048 Ventures, Ensemble VC, Spacecadet Ventures, Boost VC.
Kascaid is headquartered in San Francisco, United States.
Kascaid is developing biosensors for real-time monitoring of inflammatory biomarkers.
Kascaid is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kascaid — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/kascaid. Accessed August 14, 2026.
VCBacked. (2025). Kascaid — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kascaid
{{cite web |title=Kascaid — Funding & Investors |url=https://www.vcbacked.co/company/kascaid |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated